Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2i) as a Primary Preventative Agent in the Healthy Individual: A Need of a Future Randomised Clinical Trial?

by Dan Xu, Dan Xu, Dan Xu, Owain Chandler, Cleo Wee, Chau Ho, Jacquita S. Affandi, Daya Yang, Daya Yang, Xinxue Liao, Xinxue Liao, Wei Chen, Wei Chen, Yanbing Li, Yanbing Li, Christopher Reid, Haipeng Xiao, Haipeng Xiao
Published 2021-08-01